Immune responses of six-transmembrane epithelial antigen of the prostate 4 functions as a novel biomarker in gastric cancer

Figure 7 High expression of six-transmembrane epithelial antigen of the prostate 4 tends to be associated with poor prognosis in the patients of gastric cancer. A and B: Survival curves of overall survival (OS) and disease-free survival in the Gene Expression Profiling Interactive Analysis database (n = 384); C: Survival curves of OS in the tissue chip (n = 96); D-F: Survival curves of OS (D), post-progression survival (E), and first progression (F) in the Kaplan-Meier Plotter database (n = 875, n = 498, and n = 640). OS: Overall survival; DFS: Disease-free survival; PPS: Post-progression survival; FP: First progression.